ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Female Infertility Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-8O560
Home | Market Reports | Health| Reproductive Health
Global Female Infertility Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Female Infertility Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-8O560
Report
December 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
Ferring
Merck KGaA
Novartis
Sanofi

Female Infertility Drugs Market Size

The global Female Infertility Drugs market is projected to grow from US$ 4878.8 million in 2024 to US$ 6842.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.

Female Infertility Drugs Market

Female Infertility Drugs Market

Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia.
Market Analysis and Insights: Global Female Infertility Drugs Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Female Infertility Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Female Infertility Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Female Infertility Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Female Infertility Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Female Infertility Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Female Infertility Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Female Infertility Drugs Market Report

Report Metric Details
Report Name Female Infertility Drugs Market
Accounted market size in 2024 US$ 4878.8 million
Forecasted market size in 2030 US$ 6842.7 million
CAGR 5.8
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Parenteral
  • Oral
  • Others
Segment by Application
  • Ovarian Hyperstimulation Syndrome
  • Multiple-gestation Pregnancies
  • Multiple-birth Infants
  • Premature Labor
  • Low Birth Weight
  • Risk of Cesarean Delivery
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan Plc, Ferring BV, Merck KGaA, Novartis AG, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Female Infertility Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Female Infertility Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Female Infertility Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Female Infertility Drugs Market growing?

Ans: The Female Infertility Drugs Market witnessing a CAGR of 5.8 during the forecast period 2025-2030.

What is the Female Infertility Drugs Market size in 2030?

Ans: The Female Infertility Drugs Market size in 2030 will be US$ 6842.7 million.

Who are the main players in the Female Infertility Drugs Market report?

Ans: The main players in the Female Infertility Drugs Market are Allergan Plc, Ferring BV, Merck KGaA, Novartis AG, Sanofi

What are the Application segmentation covered in the Female Infertility Drugs Market report?

Ans: The Applications covered in the Female Infertility Drugs Market report are Ovarian Hyperstimulation Syndrome, Multiple-gestation Pregnancies, Multiple-birth Infants, Premature Labor, Low Birth Weight, Risk of Cesarean Delivery

What are the Type segmentation covered in the Female Infertility Drugs Market report?

Ans: The Types covered in the Female Infertility Drugs Market report are Parenteral, Oral, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Female Infertility Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Parenteral
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Female Infertility Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Ovarian Hyperstimulation Syndrome
1.3.3 Multiple-gestation Pregnancies
1.3.4 Multiple-birth Infants
1.3.5 Premature Labor
1.3.6 Low Birth Weight
1.3.7 Risk of Cesarean Delivery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Female Infertility Drugs Market Perspective (2019-2030)
2.2 Global Female Infertility Drugs Growth Trends by Region
2.2.1 Female Infertility Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Female Infertility Drugs Historic Market Size by Region (2019-2024)
2.2.3 Female Infertility Drugs Forecasted Market Size by Region (2025-2030)
2.3 Female Infertility Drugs Market Dynamics
2.3.1 Female Infertility Drugs Industry Trends
2.3.2 Female Infertility Drugs Market Drivers
2.3.3 Female Infertility Drugs Market Challenges
2.3.4 Female Infertility Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Female Infertility Drugs by Players
3.1.1 Global Female Infertility Drugs Revenue by Players (2019-2024)
3.1.2 Global Female Infertility Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Female Infertility Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Female Infertility Drugs Market Concentration Ratio
3.4.1 Global Female Infertility Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Female Infertility Drugs Revenue in 2023
3.5 Global Key Players of Female Infertility Drugs Head office and Area Served
3.6 Global Key Players of Female Infertility Drugs, Product and Application
3.7 Global Key Players of Female Infertility Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Female Infertility Drugs Breakdown Data by Type
4.1 Global Female Infertility Drugs Historic Market Size by Type (2019-2024)
4.2 Global Female Infertility Drugs Forecasted Market Size by Type (2025-2030)
5 Female Infertility Drugs Breakdown Data by Application
5.1 Global Female Infertility Drugs Historic Market Size by Application (2019-2024)
5.2 Global Female Infertility Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Female Infertility Drugs Market Size (2019-2030)
6.2 North America Female Infertility Drugs Market Size by Type
6.2.1 North America Female Infertility Drugs Market Size by Type (2019-2024)
6.2.2 North America Female Infertility Drugs Market Size by Type (2025-2030)
6.2.3 North America Female Infertility Drugs Market Share by Type (2019-2030)
6.3 North America Female Infertility Drugs Market Size by Application
6.3.1 North America Female Infertility Drugs Market Size by Application (2019-2024)
6.3.2 North America Female Infertility Drugs Market Size by Application (2025-2030)
6.3.3 North America Female Infertility Drugs Market Share by Application (2019-2030)
6.4 North America Female Infertility Drugs Market Size by Country
6.4.1 North America Female Infertility Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Female Infertility Drugs Market Size by Country (2019-2024)
6.4.3 North America Female Infertility Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Female Infertility Drugs Market Size (2019-2030)
7.2 Europe Female Infertility Drugs Market Size by Type
7.2.1 Europe Female Infertility Drugs Market Size by Type (2019-2024)
7.2.2 Europe Female Infertility Drugs Market Size by Type (2025-2030)
7.2.3 Europe Female Infertility Drugs Market Share by Type (2019-2030)
7.3 Europe Female Infertility Drugs Market Size by Application
7.3.1 Europe Female Infertility Drugs Market Size by Application (2019-2024)
7.3.2 Europe Female Infertility Drugs Market Size by Application (2025-2030)
7.3.3 Europe Female Infertility Drugs Market Share by Application (2019-2030)
7.4 Europe Female Infertility Drugs Market Size by Country
7.4.1 Europe Female Infertility Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Female Infertility Drugs Market Size by Country (2019-2024)
7.4.3 Europe Female Infertility Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Female Infertility Drugs Market Size (2019-2030)
8.2 China Female Infertility Drugs Market Size by Type
8.2.1 China Female Infertility Drugs Market Size by Type (2019-2024)
8.2.2 China Female Infertility Drugs Market Size by Type (2025-2030)
8.2.3 China Female Infertility Drugs Market Share by Type (2019-2030)
8.3 China Female Infertility Drugs Market Size by Application
8.3.1 China Female Infertility Drugs Market Size by Application (2019-2024)
8.3.2 China Female Infertility Drugs Market Size by Application (2025-2030)
8.3.3 China Female Infertility Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Female Infertility Drugs Market Size (2019-2030)
9.2 Asia Female Infertility Drugs Market Size by Type
9.2.1 Asia Female Infertility Drugs Market Size by Type (2019-2024)
9.2.2 Asia Female Infertility Drugs Market Size by Type (2025-2030)
9.2.3 Asia Female Infertility Drugs Market Share by Type (2019-2030)
9.3 Asia Female Infertility Drugs Market Size by Application
9.3.1 Asia Female Infertility Drugs Market Size by Application (2019-2024)
9.3.2 Asia Female Infertility Drugs Market Size by Application (2025-2030)
9.3.3 Asia Female Infertility Drugs Market Share by Application (2019-2030)
9.4 Asia Female Infertility Drugs Market Size by Region
9.4.1 Asia Female Infertility Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Female Infertility Drugs Market Size by Region (2019-2024)
9.4.3 Asia Female Infertility Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Female Infertility Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Female Infertility Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Female Infertility Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Details
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Female Infertility Drugs Introduction
11.1.4 Allergan Plc Revenue in Female Infertility Drugs Business (2019-2024)
11.1.5 Allergan Plc Recent Developments
11.2 Ferring BV
11.2.1 Ferring BV Company Details
11.2.2 Ferring BV Business Overview
11.2.3 Ferring BV Female Infertility Drugs Introduction
11.2.4 Ferring BV Revenue in Female Infertility Drugs Business (2019-2024)
11.2.5 Ferring BV Recent Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Female Infertility Drugs Introduction
11.3.4 Merck KGaA Revenue in Female Infertility Drugs Business (2019-2024)
11.3.5 Merck KGaA Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Female Infertility Drugs Introduction
11.4.4 Novartis AG Revenue in Female Infertility Drugs Business (2019-2024)
11.4.5 Novartis AG Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Female Infertility Drugs Introduction
11.5.4 Sanofi Revenue in Female Infertility Drugs Business (2019-2024)
11.5.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Allergan plc
Ferring
Merck KGaA
Novartis
Sanofi
List of Tables
    Table 1. Global Female Infertility Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Parenteral
    Table 3. Key Players of Oral
    Table 4. Key Players of Others
    Table 5. Global Female Infertility Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Female Infertility Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Female Infertility Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Female Infertility Drugs Market Share by Region (2019-2024)
    Table 9. Global Female Infertility Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Female Infertility Drugs Market Share by Region (2025-2030)
    Table 11. Female Infertility Drugs Market Trends
    Table 12. Female Infertility Drugs Market Drivers
    Table 13. Female Infertility Drugs Market Challenges
    Table 14. Female Infertility Drugs Market Restraints
    Table 15. Global Female Infertility Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Female Infertility Drugs Revenue Share by Players (2019-2024)
    Table 17. Global Top Female Infertility Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Infertility Drugs as of 2023)
    Table 18. Global Female Infertility Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Female Infertility Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Female Infertility Drugs, Headquarters and Area Served
    Table 21. Global Key Players of Female Infertility Drugs, Product and Application
    Table 22. Global Key Players of Female Infertility Drugs, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Female Infertility Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Female Infertility Drugs Revenue Market Share by Type (2019-2024)
    Table 26. Global Female Infertility Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Female Infertility Drugs Revenue Market Share by Type (2025-2030)
    Table 28. Global Female Infertility Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Female Infertility Drugs Revenue Share by Application (2019-2024)
    Table 30. Global Female Infertility Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Female Infertility Drugs Revenue Share by Application (2025-2030)
    Table 32. North America Female Infertility Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Female Infertility Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Female Infertility Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Female Infertility Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Female Infertility Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Female Infertility Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Female Infertility Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Female Infertility Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Female Infertility Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Female Infertility Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Female Infertility Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Female Infertility Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Female Infertility Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Female Infertility Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Female Infertility Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Female Infertility Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Female Infertility Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Female Infertility Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Female Infertility Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Female Infertility Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Female Infertility Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Female Infertility Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Female Infertility Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Female Infertility Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Female Infertility Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Female Infertility Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Female Infertility Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Allergan Plc Company Details
    Table 65. Allergan Plc Business Overview
    Table 66. Allergan Plc Female Infertility Drugs Product
    Table 67. Allergan Plc Revenue in Female Infertility Drugs Business (2019-2024) & (US$ Million)
    Table 68. Allergan Plc Recent Developments
    Table 69. Ferring BV Company Details
    Table 70. Ferring BV Business Overview
    Table 71. Ferring BV Female Infertility Drugs Product
    Table 72. Ferring BV Revenue in Female Infertility Drugs Business (2019-2024) & (US$ Million)
    Table 73. Ferring BV Recent Developments
    Table 74. Merck KGaA Company Details
    Table 75. Merck KGaA Business Overview
    Table 76. Merck KGaA Female Infertility Drugs Product
    Table 77. Merck KGaA Revenue in Female Infertility Drugs Business (2019-2024) & (US$ Million)
    Table 78. Merck KGaA Recent Developments
    Table 79. Novartis AG Company Details
    Table 80. Novartis AG Business Overview
    Table 81. Novartis AG Female Infertility Drugs Product
    Table 82. Novartis AG Revenue in Female Infertility Drugs Business (2019-2024) & (US$ Million)
    Table 83. Novartis AG Recent Developments
    Table 84. Sanofi Company Details
    Table 85. Sanofi Business Overview
    Table 86. Sanofi Female Infertility Drugs Product
    Table 87. Sanofi Revenue in Female Infertility Drugs Business (2019-2024) & (US$ Million)
    Table 88. Sanofi Recent Developments
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Female Infertility Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Female Infertility Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Parenteral Features
    Figure 4. Oral Features
    Figure 5. Others Features
    Figure 6. Global Female Infertility Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Female Infertility Drugs Market Share by Application: 2023 VS 2030
    Figure 8. Ovarian Hyperstimulation Syndrome Case Studies
    Figure 9. Multiple-gestation Pregnancies Case Studies
    Figure 10. Multiple-birth Infants Case Studies
    Figure 11. Premature Labor Case Studies
    Figure 12. Low Birth Weight Case Studies
    Figure 13. Risk of Cesarean Delivery Case Studies
    Figure 14. Female Infertility Drugs Report Years Considered
    Figure 15. Global Female Infertility Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Female Infertility Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Female Infertility Drugs Market Share by Region: 2023 VS 2030
    Figure 18. Global Female Infertility Drugs Market Share by Players in 2023
    Figure 19. Global Top Female Infertility Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Infertility Drugs as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Female Infertility Drugs Revenue in 2023
    Figure 21. North America Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Female Infertility Drugs Market Share by Type (2019-2030)
    Figure 23. North America Female Infertility Drugs Market Share by Application (2019-2030)
    Figure 24. North America Female Infertility Drugs Market Share by Country (2019-2030)
    Figure 25. United States Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Female Infertility Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Female Infertility Drugs Market Share by Type (2019-2030)
    Figure 29. Europe Female Infertility Drugs Market Share by Application (2019-2030)
    Figure 30. Europe Female Infertility Drugs Market Share by Country (2019-2030)
    Figure 31. Germany Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Female Infertility Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Female Infertility Drugs Market Share by Type (2019-2030)
    Figure 39. China Female Infertility Drugs Market Share by Application (2019-2030)
    Figure 40. Asia Female Infertility Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Female Infertility Drugs Market Share by Type (2019-2030)
    Figure 42. Asia Female Infertility Drugs Market Share by Application (2019-2030)
    Figure 43. Asia Female Infertility Drugs Market Share by Region (2019-2030)
    Figure 44. Japan Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Female Infertility Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Female Infertility Drugs Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Female Infertility Drugs Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Female Infertility Drugs Market Share by Country (2019-2030)
    Figure 54. Brazil Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Female Infertility Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Allergan Plc Revenue Growth Rate in Female Infertility Drugs Business (2019-2024)
    Figure 61. Ferring BV Revenue Growth Rate in Female Infertility Drugs Business (2019-2024)
    Figure 62. Merck KGaA Revenue Growth Rate in Female Infertility Drugs Business (2019-2024)
    Figure 63. Novartis AG Revenue Growth Rate in Female Infertility Drugs Business (2019-2024)
    Figure 64. Sanofi Revenue Growth Rate in Female Infertility Drugs Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Contraceptive Implants Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-28O9658
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global HIV Diagnostic Test Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-3S1302
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Premature Ovarian Failure Cure Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23R7583
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Peyronie’s Disease Treatment Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-27T5728
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions